Cargando…
Genotype-driven therapeutic developments in Parkinson’s disease
BACKGROUND: Remarkable advances have been reached in the understanding of the genetic basis of Parkinson’s disease (PD), with the identification of monogenic causes (mPD) and a plethora of gene loci leading to an increased risk for idiopathic PD. The expanding knowledge and subsequent identification...
Autores principales: | Prasuhn, Jannik, Brüggemann, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056568/ https://www.ncbi.nlm.nih.gov/pubmed/33874883 http://dx.doi.org/10.1186/s10020-021-00281-8 |
Ejemplares similares
-
Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson’s Disease
por: Prasuhn, Jannik, et al.
Publicado: (2021) -
Neuroinflammation and Mitochondrial Dysfunction in Parkinson’s Disease: Connecting Neuroimaging with Pathophysiology
por: Pizarro-Galleguillos, Benjamin Matís, et al.
Publicado: (2023) -
Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson’s Disease
por: Pizarro-Galleguillos, Benjamin Matis, et al.
Publicado: (2022) -
A machine learning-based classification approach on Parkinson’s disease diffusion tensor imaging datasets
por: Prasuhn, Jannik, et al.
Publicado: (2020) -
Neuroimaging Methods to Map In Vivo Changes of OXPHOS and Oxidative Stress in Neurodegenerative Disorders
por: Prasuhn, Jannik, et al.
Publicado: (2022)